| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.06 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.06 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.06 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.06 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.24 | 0.06 |